Vascular-Access-Port Withdrawl-Blood LJT
by Norfolk Medical Products, Inc.
510(k) K841679
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK841679 | Date28 Jun 1984 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Vascular-Access-Port Withdrawl-Blood
- 510(k) Number
- FDA Product Code
- LJT
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.5965
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
This device is a Port & Catheter, Implanted, Subcutaneous, Intravascular, designed for vascular access to facilitate blood withdrawal. It is a subcutaneous implantable port system used to provide reliable and repeated access to the venous system for therapeutic or diagnostic procedures requiring phlebotomy.
The Vascular-Access-Port Withdrawl-Blood LJT is intended for single-use implantation and is regulated under FDA 510(k) clearance (K841679) as substantially equivalent to a predicate device. It is supplied sterile and intended for use in general hospital settings, adhering to medical specialty standards for vascular access solutions. The device is classified under regulation number 880.5965 and is not intended for reusable applications.
From the manufacturer
From the first human implant of a vascular access port (VAP) in 1982, to the first omni-directional access port in 1991, to the dynamic TidalPort™ of today, Norfolk Medical has pioneered innovative, cost-effective access solutions.